Correlation Between RenovoRx and Beam Therapeutics
Can any of the company-specific risk be diversified away by investing in both RenovoRx and Beam Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining RenovoRx and Beam Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between RenovoRx and Beam Therapeutics, you can compare the effects of market volatilities on RenovoRx and Beam Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in RenovoRx with a short position of Beam Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of RenovoRx and Beam Therapeutics.
Diversification Opportunities for RenovoRx and Beam Therapeutics
0.35 | Correlation Coefficient |
Weak diversification
The 3 months correlation between RenovoRx and Beam is 0.35. Overlapping area represents the amount of risk that can be diversified away by holding RenovoRx and Beam Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Beam Therapeutics and RenovoRx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on RenovoRx are associated (or correlated) with Beam Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Beam Therapeutics has no effect on the direction of RenovoRx i.e., RenovoRx and Beam Therapeutics go up and down completely randomly.
Pair Corralation between RenovoRx and Beam Therapeutics
Given the investment horizon of 90 days RenovoRx is expected to generate 1.74 times more return on investment than Beam Therapeutics. However, RenovoRx is 1.74 times more volatile than Beam Therapeutics. It trades about 0.03 of its potential returns per unit of risk. Beam Therapeutics is currently generating about -0.01 per unit of risk. If you would invest 190.00 in RenovoRx on August 29, 2024 and sell it today you would lose (54.00) from holding RenovoRx or give up 28.42% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
RenovoRx vs. Beam Therapeutics
Performance |
Timeline |
RenovoRx |
Beam Therapeutics |
RenovoRx and Beam Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with RenovoRx and Beam Therapeutics
The main advantage of trading using opposite RenovoRx and Beam Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if RenovoRx position performs unexpectedly, Beam Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Beam Therapeutics will offset losses from the drop in Beam Therapeutics' long position.RenovoRx vs. Adial Pharmaceuticals | RenovoRx vs. Pasithea Therapeutics Corp | RenovoRx vs. Quoin Pharmaceuticals Ltd | RenovoRx vs. Nutriband |
Beam Therapeutics vs. Valneva SE ADR | Beam Therapeutics vs. Bright Minds Biosciences | Beam Therapeutics vs. HP Inc | Beam Therapeutics vs. Intel |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |